Reply to Gohar on ‘Lungs, methotrexate and psoriasis’, a comment on ‘Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long‐term low‐dose methotrexate for psoriasis’

Case reports and narrative fallacies: the enigma of black swans in dermatology

“…Case reports are used to broaden clinicians’ perspectives by highlighting unique presentations that are unlikely to be seen in routine clinical practice, 18 and global cases in low‐resource settings 19 . Furthermore, they can be used to stimulate debate and question conventional thinking 20 . This helps combat hubris in medicine and prevents automatic acceptance of current medical practice.…”

Response to ‘Reply to Gohar on “Lungs, methotrexate and psoriasis”, a comment on “Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long‐term low‐dose methotrexate for psoriasis”’

“…Response to 'Reply to Gohar on "Lungs, methotrexate and psoriasis", a comment on "Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis"' 3 I understand that the terms used in describing interstitial lung disease or diffuse parenchymal lung disease entities have been confusing and that establishing an accurate diagnosis of idiopathic pulmonary fibrosis can be challenging. [4][5][6] While routine chest computed tomography may not be justified in all patents with psoriasis, I believe that it should be considered prior to prescribing methotrexate.…”